Evaluation of immune persistence after rabies vaccination in 150 people.
150 subjects aged 10-60 were recruited to inoculate the frozen human rabies vaccine (Vero cells) produced and marketed by Changchun Zhuoyi Biological Co., Ltd. in the whole process of 0, 3, 7, 14 and 28 day immunization. The immunogenicity persistence and safety of the test vaccine were evaluated 14 days, 6 months and 12 months after the whole process of vaccination.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
149
Inoculate 5 doses of rabies vaccine, and collect blood at fixed time points to detect neutralizing antibody
Changchun Zhuoyi Biological Co., Ltd
Changchun, Jilin, China
positive conversion rate evaluation (6 months)
Evaluate the positive conversion rate 6 months after vaccination of rabies vaccine according to the 5-dose immunization program
Time frame: 6 months
antibody titer evaluation (6 months)
Evaluate the antibody titer of serum neutralizing antibody 6 months after vaccination of rabies vaccine according to the 5-dose immunization program
Time frame: 6 months
positive conversion rate evaluation (12 months)
Evaluate the positive conversion rate 12 months after vaccination of rabies vaccine according to the 5-dose immunization program
Time frame: 12 months
antibody titer evaluation (12 months)
Evaluate the antibody titer of serum neutralizing antibody 12 months after vaccination of rabies vaccine according to the 5-dose immunization program
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.